From: Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis
| ncRNAs | Detected in cell/tissue | Expression | Target gene(s)/acting pathway | Reported function(s) | References | |
|---|---|---|---|---|---|---|
| miR-93 | Adipose tissue | ↑ | GLUT4 | Correlated with insulin resistance | [26] | |
| Granulose cells | ↑ | CDKN1A | Promotes proliferation and cell cycle progression | [27] | ||
| Granulose cells | ↑ | SMAD7 and TGFBR2 | Impaired follicle development | [49] | ||
| Plasma | ↑ | NGF Signalling and HGF Signalling | Correlated with insulin resistance | [32] | ||
| miR-320 | Serum | ↓ | Through ET-1 regulating ERK1/2 signalling pathway | Promotes cell mitosis | [44] | |
| Cumulus cells | ↓ | RUNX2 | Estrogen deficiency | [58] | ||
| Ovarian tissue | ↓ | Through IRS-1 regulating ERK1/2 signalling pathway | Inhibits insulin resistance | [72] | ||
| Follicular fluid | ↓ | RAB5B | Correlated with insulin resistance | [25] | ||
| Follicular fluid, granulosa cells | ↑ | E2F1 and SF-1 | Inhibited estradiol release and cell proliferation; enhanced progesterone synthesis | [46] | ||
| miR-9 | Follicular fluid | ↑ | IRS2, SYT1, IL8 | Mediates the effects of insulin; steroid synthesis | [45] | |
| miR-18b | Follicular fluid | ↑ | IRS2, SYT1, IL8 | Mediates the effects of insulin; steroid synthesis | [45] | |
| miR-135a | Follicular fluid | ↑ | IRS2, SYT1, IL8 | Mediates the effects of insulin; steroid synthesis | [45] | |
| Granulosa cells | ↑ | ESR2 | Promoted proliferation and inhibited apoptosis | [67] | ||
| miR-186 | Granulosa cells | ↑ | ESR2 | Promoted proliferation and inhibited apoptosis | [67] | |
| miR-21 | Serum | ↑ | LATS1 | Promotes secondary follicle growth | [31] | |
| Granulose cells | ↑ | SMAD7 and TGFBR2 | Impaired follicle development | [49] | ||
| miR-592 | Serum | ↓ | LHCGR | Inhibited cell viability and cell cycle progression | [33] | |
| miR-92a | Ovarian theca interna tissues | ↓ | GATA-6 and IRS-2 | Related to androgenic and insulin signaling pathways | [17] | |
| miR-223 | Plasma | ↑ | PPAR, IGF-1 and angiopoietin signaling | Correlated with insulin resistance hyperandrogenism, endometrial response and ovarian follicle development | [32] | |
| miR-483 | Ovary cortex | ↓ | IGF1 | Inhibits cell proliferation | [71] | |
| miR-483-5p | Cumulus granulosa cells | ↓ | Notch3 and MAPK3 | Related to cell proliferation and apoptosis | [55] | |
| Cumulus cells | ↓ | IGF2 | Inhibits insulin resistance | [53] | ||
| miR-486-5p | Cumulus cells | ↓ | PI3K/Akt | Promote cumulus cell proliferation | [53] | |
| miR-509-3p | Cumulus cells | ↑ | MAP3K8 | Improved oestradiol secretion | [56] | |
| miR-6767-5p | Serum | ↓ | Negatively associated with fasting glucose | [36] | ||
| miR-145 | Granulosa cells | ↓ | IRS1 | Negatively Regulates Cell Proliferation | [57] | |
| miR-126-5p | Granulosa cells | ↓ | Klotho-associated signaling | Involved in apoptosis of cells | [60] | |
| miR-29a-5p | Granulosa cells | ↓ | Klotho-associated signaling | Involved in apoptosis of cells | [60] | |
| miR-27a-3p | Granulosa cells | ↑ | SMAD5 | Decreased cell proliferation and promoted cell apoptosis | [61] | |
| miR-335-5p | Follicular fluid | ↓ | SGK3 | Involved in granulosa cells proliferation | [51] | |
| miR-873-5p | Follicular fluid | ↑ | Heme oxygenase-1 (HO-1) | Involved in apoptosis of cells | [52] | |
| miR-19b | Granulosa cells | ↓ | IGF-1 | Promotes cell proliferation | [62] | |
| miR-99a | Granulosa cells | ↑ | IGF-1 | Regulates proliferation and apoptosis | [63] | |
| miR-33b | Granulosa cells | ↑ | TGFBR1 | Induced dysregulated cell proliferation, apoptosis, and cell cycle | [64] | |
| miR-142 | Granulosa cells | ↑ | TGFBR1 | Induced dysregulated cell proliferation, apoptosis, and cell cycle | [64] | |
| miR-423 | Granulosa cells | ↓ | SMAD7 | Induced dysregulated cell proliferation, apoptosis, and cell cycle | [64] | |
| miR-23a | Granulosa cells | ↑ | SIRT1 | Promotes cell apoptosis | [65] | |
| miR-130b-3p | Ovarian theca cells | ↑ | DENND1A Variant 2 | Correlated with androgen biosynthesis | [73] | |
| lncRNA CTBP1-AS | Peripheral blood leukocytes | ↑ | Reguletes androgen receptor AR activity | [79] | ||
| lncRNA SRA | Peripheral blood leukocytes | ↑ | Promote activity of steroid receptors | [80] | ||
| lncRNA PWRN2 | Cumulus cells | ↑ | miR-92b-3p and TMEM120B | Correlated with oocyte nuclear maturation | [83] | |
| lncRNA GAS5 | Serum | ↓ | Correlated with insulin resistance,cell apoptosis and proliferation | [85] | ||
| lncRNA BANCR | Granulosa cells | ↑ | Bax and p53 | promote apoptosis | [87] | |
| lncRNA LINC-01572:28 | Luteinized granulosa cells | ↑ | SKP2 and p27 | inhibits cell proliferation and cell cycle | [86] | |
| lncRNA H19 | Peripheral blood leukocytes | ↑ | correlated with fasting plasma glucose levels | [88] | ||